GAM
EW icon

Generali Asset Management’s Edwards Lifesciences EW Stock Holding History

Generali Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.94M Sell
54,627
-8,168
-13% -$684K 0.09% 199
2026
Q1 		$5.03M Sell
62,795
-9,744
-13% -$803K 0.1% 185
2025
Q4 		$6.18M Buy
72,539
+32,174
+80% +$2.64M 0.13% 154
2025
Q3 		$3.14M Buy
40,365
+1,244
+3% +$97.2K 0.07% 234
2025
Q2 		$3.06M Buy
39,121
+3,732
+11% +$278K 0.07% 235
2025
Q1 		$2.56M Buy
35,389
+3,648
+11% +$261K 0.06% 271
2024
Q4 		$2.35M Buy
+31,741
New +$2.22M 0.06% 292

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Generali Asset Management's EW Position: Q2 2026 in Review

Generali Asset Management reduced its Edwards Lifesciences (EW) stake by 13% in Q2 2026, selling an estimated $684K and leaving 54,627 shares worth $4.94M. The position accounts for 0.09% of the portfolio, ranked #199.

Generali Asset Management first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.18M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Generali Asset Management held 54,627 shares of Edwards Lifesciences worth $4.94M as of Q2 2026.
  • Generali Asset Management sold 8,168 Edwards Lifesciences shares in Q2 2026, an estimated $684K.
  • Edwards Lifesciences made up 0.09% of Generali Asset Management's portfolio in Q2 2026, its #199 holding.
  • Generali Asset Management first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Edwards Lifesciences position peaked at $6.18M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.